DocGo reported a significant decrease in revenue and a net loss in the first quarter of 2025, primarily due to the planned wind-down of migrant-related programs. The company updated its full-year 2025 guidance downward, removing non-migrant municipal population health revenue, while highlighting growth in its Medical Transportation and Payer & Provider businesses.
Revenue significantly decreased year-over-year due to migrant program wind-down.
Company shifted focus and guidance to Medical Transportation and Payer & Provider segments.
Full-year 2025 guidance was significantly lowered, projecting an Adjusted EBITDA loss.
Medical Transportation segment achieved record revenue and trip volume.
DocGo updated its full-year 2025 guidance, lowering revenue expectations to $300-$330 million and projecting an adjusted EBITDA loss of $20-$30 million, primarily due to the removal of non-migrant municipal population health revenue.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance